دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Table of Contents
doi : 10.1016/S0012-3692(22)03743-6
Volume 162, Issue 5, November 2022, Pages A13-A14, A16, A19-A20, A23-A25
General Information
doi : 10.1016/S0012-3692(22)03742-4
Volume 162, Issue 5, November 2022, Page A26
Single vs Multiple Inhaler Triple Therapy in the COPD Population
Eunice E. Cho, MD Andrea S. Gershon, MD
doi : 10.1016/j.chest.2022.09.004
Volume 162, Issue 5, November 2022, Pages 947-948
What End-of-Life Communication in ICUs Around the World Teaches Us About Shared Decision-Making
Komal Patel Murali, PhD, RN, ACNP-BC May Hua, MD
doi : 10.1016/j.chest.2022.07.001
Volume 162, Issue 5, November 2022, Pages 949-950
Septic Shock in Patients With Solid Malignancies: What Does the Host Response Yield When the Host Is Already Under Threat?
Patrick G. Lyons, MD Colleen A. McEvoy, MD
doi : 10.1016/j.chest.2022.06.035
Volume 162, Issue 5, November 2022, Pages 951-953
Obesity and Sarcoidosis Risk: An Index Under Suspicion
Yvette C. Cozier, DSc, MPH Praveen Govender, MD Jeffrey S. Berman, MD
doi : 10.1016/j.chest.2022.07.019
Volume 162, Issue 5, November 2022, Pages 954-956
The Value of Cardiopulmonary Exercise Testing as a Predictor of Mortality in Heart Failure
Richard Casaburi, PhD, MD, FCCP
doi : 10.1016/j.chest.2022.06.010
Volume 162, Issue 5, November 2022, Pages 957-958
Time to Use Direct Oral Anticoagulants to Prevent Recurrences and Major Acute Cardiovascular Events After VTE?
Cecilia Becattini, MD Maria Cristina Vedovati, MD
doi : 10.1016/j.chest.2022.08.2201
Volume 162, Issue 5, November 2022, Pages 959-960
Treatment of Intranasal Corticosteroids for OSA Syndrome: Is the Juice Worth the Squeeze?
Fauziya Hassan, MD Ann Arbor, MI Kristie Ross, MD
doi : 10.1016/j.chest.2022.08.2236
Volume 162, Issue 5, November 2022, Pages 961-962
Preoperative Biopsy Does Not Generate STAS?
Hironori Uruga, MD, PhDMari Mino-Kenudson, MD
doi : 10.1016/j.chest.2022.06.021
Volume 162, Issue 5, November 2022, Pages 963-964
Welcome to the Real World: Understanding the Many Faces of Osimertinib-Related Pneumonitis
Jennifer D. Possick, MD
doi : 10.1016/j.chest.2022.06.020
Volume 162, Issue 5, November 2022, Pages 965-967
Not all Blebs Are Created Equal
Preeti Gupta, MD, MPH Christopher M. Kapp, MD
doi : 10.1016/j.chest.2022.06.015
Volume 162, Issue 5, November 2022, Pages 968-969
POINT: Is Chronic Bacterial Infection Clinically Relevant in COPD? Yes
Miguel Ã�ngel MartÃnez-GarcÃa, MD Valencia, Spain Alvar Agusti, MD
doi : 10.1016/j.chest.2022.07.010
Volume 162, Issue 5, November 2022, Pages 970-972
COUNTERPOINT: Is Chronic Bacterial Infection Clinically Relevant in COPD? No
Holly R. Keir, PhD James D. Chalmers, PhD
doi : 10.1016/j.chest.2022.07.009
Volume 162, Issue 5, November 2022, Pages 972-976
Rebuttal From Drs Martinez-Garcia and Agusti
Miguel Ã�ngel MartÃnez-GarcÃa, MD Valencia, Spain Alvar Agusti, MD
doi : 10.1016/j.chest.2022.07.011
Volume 162, Issue 5, November 2022, Pages 976-977
Rebuttal From Dr Keir and Prof Chalmers
Holly R. Keir, PhD James D. Chalmers, PhD
doi : 10.1016/j.chest.2022.07.012
Volume 162, Issue 5, November 2022, Pages 977-978
Why Sepsis Survivors Need an ICD-10 Code for “Sepsis Aftercare�
Sungho Oh, PhD, RN Philadelphia, PA Mark E. Mikkelsen, MD, MSCE Aurora, CO Melissa O’Connor, PhD, RN Kathryn H. Bowles, PhD, RN
doi : 10.1016/j.chest.2022.06.011
Volume 162, Issue 5, November 2022, Pages 979-981
Neutralizing COVID-19 Convalescent Plasma in Adults Hospitalized With COVID-19: A Blinded, Randomized, Placebo-Controlled Trial
Wesley H. Self, MD, MPH; Allison P. Wheeler, MD; Thomas G. Stewart, PhD; Harry Schrager, MD; Jason Mallada, PharmD, BCIDP; Christopher B. Thomas, MD; Vince D. Cataldo, MD; Hollis R. O’Neal Jr, MD; Nathan I. Shapiro, MD, MPH; Conor Higgins, BS; Adit A. Ginde, MD, MPH; Lakshmi Chauhan, MD; Nicholas J. Johnson, MD; Daniel J. Henning, MD, MPH; Stuti J. Jaiswal, MD, PhD; Manoj J. Mammen, MD; Estelle S. Harris, MD; Sonal R. Pannu, MD; Maryrose Laguio-Vila, MD; Wissam El Atrouni, MD; Marjolein de Wit, MD; Daanish Hoda, MD; Claudia S. Cohn, MD, PhD; Carla McWilliams, MD; Carl Shanholtz, MD; Alan E. Jones, MD; Jay S. Raval, MD; Simon Mucha, MD; Tina S. Ipe, MD, MPH; Xian Qiao, MD; Stephen J. Schrantz, MD; Aarthi Shenoy, MD; Richard D. Fremont, MD; Eric J. Brady, BS; Robert H. Carnahan, PhD; James D. Chappell, MD, PhD; James E. Crowe Jr, MD; Mark R. Denison, MD; Pavlo Gilchuk, PhD; Laura J. Stevens, MS; Rachel E. Sutton; Isaac Thomsen, MD; Sandra M. Yoder, MT (ASCP), SCYM; Amanda J. Bistran-Hall, BS; Jonathan D. Casey, MD; Christopher J. Lindsell, PhD; Li Wang, MS; Jill M. Pulley, MBA; Jillian P. Rhoads, PhD; Gordon R. Bernard, MD; and Todd W. Rice, MD; for the Passive Immunity Trial for Our Nation (PassITON) Investigators
doi : 10.1016/j.chest.2022.06.029
Volume 162, Issue 5, November 2022, Pages 982-994
Deep Learning-Based Prediction Model Using Radiography in Nontuberculous Mycobacterial Pulmonary Disease
Seowoo Lee, MD; Hyun Woo Lee, MD; Hyung-Jun Kim, MD; Deog Kyeom Kim, PhD; Jae-Joon Yim, MD; Soon Ho Yoon, PhD; and Nakwon Kwak, MD
doi : 10.1016/j.chest.2022.06.018
Volume 162, Issue 5, November 2022, Pages 995-1005
Neutrophil Extracellular Traps, Local IL-8 Expression, and Cytotoxic T-Lymphocyte Response in the Lungs of Patients With Fatal COVID-19
Ignacio Melero, MD, PhD; MarÃa Villalba-Esparza, PhD; Borja Recalde-Zamacona, MD; Daniel Jiménez-Sánchez, PhD; Ã�lvaro Teijeira, PhD; Alan Argueta, MD; Laura GarcÃa-Tobar, MD; Laura Ã�lvarez-Gigli, MD; Cristina Sainz, BSc; David Garcia-Ros, BSc; EstefanÃa Toledo, MD, PhD; Marta Abengozar-Muela, MD; Mirian Fernández-Alonso, PhD; Mariano RodrÃguez-Mateos, MD, PhD; Gabriel Reina, MD, PhD; Francisco Carmona-Torre, MD, PhD; Jorge Augusto Quiroga, MD, PhD; Jose L. Del Pozo, MD, PhD; Amy Cross, PhD; Ã�lvaro López-Janeiro, MD; David Hardisson, MD, PhD; José I. Echeveste, MD, PhD; Maria D. Lozano, MD, PhD; Ling-Pei Ho, MD, PhD; Paul Klenerman, MD, PhD; Fadi Issa, DPhil; Manuel F. Landecho, MD, PhD; and Carlos E. de Andrea, MD, PhD
doi : 10.1016/j.chest.2022.06.007
Volume 162, Issue 5, November 2022, Pages 1006-1016
Clinical Characteristics, Treatment Persistence, and Outcomes Among Patients With COPD Treated With Single- or Multiple-Inhaler Triple Therapy: A Retrospective Analysis in Spain
Bernardino Alcázar-Navarrete, MD; LucÃa Jamart, BSc; JoaquÃn Sánchez-Covisa, MSc; Mónica Juárez, BSc; Ruth Graefenhain, MSc; and Antoni Sicras-Mainar, MD
doi : 10.1016/j.chest.2022.06.033
Volume 162, Issue 5, November 2022, Pages 1017-1029
V̇/Q̇ Mismatch: A Novel Target for COPD Treatment
J. Alberto Neder, MD; Miranda Kirby, PhD; Giles Santyr, PhD; Marina Pourafkari, MD; Reginald Smyth, BSc; Devin B. Phillips, PhD; Sophie Crinion, MD; Juan Pablo de-Torres, MD; and Denis E. O’Donnell, MD
doi : 10.1016/j.chest.2022.03.033
Volume 162, Issue 5, November 2022, Pages 1030-1047
The Impact of Sample Size Misestimations on the Interpretation of ARDS Trials: Systematic Review and Meta-analysis
Rohit Saha, MD; Benjamin Assouline, MD; Georgina Mason, MD; Abdel Douiri, PhD; Charlotte Summers, PhD; and Manu Shankar-Hari, PhD
doi : 10.1016/j.chest.2022.05.018
Volume 162, Issue 5, November 2022, Pages 1048-1062
Outcomes and Predictors of 28-Day Mortality in Patients With Solid Tumors and Septic Shock Defined by Third International Consensus Definitions for Sepsis and Septic Shock Criteria
John A. Cuenca, MD; Nirmala K. Manjappachar, MD; Claudia M. RamÃrez, MD; Mike Hernandez, MS; Peyton Martin, BS; Cristina Gutierrez, MD; Nisha Rathi, MD; Charles L. Sprung, MD; Kristen J. Price, MD; and Joseph L. Nates, MD, CMQ, MCCM
doi : 10.1016/j.chest.2022.05.017
Volume 162, Issue 5, November 2022, Pages 1063-1073
Global Comparison of Communication of End-of-Life Decisions in the ICU
Charles Feldman, DSc; Charles L. Sprung, MD; Spyros D. Mentzelopoulos, MD; Anne Pohrt, Dipl-Math; Christiane S. Hartog, MD; Christopher Danbury, MPhil; Manfred Weiss, MD; Alexander Avidan, MD; Angel Estella, MD; Gavin M. Joynt, MB BCh; Alexandre Lautrette, MD; Edoardo Geat, MD; Gábor Él}o, MD; Eldar Søreide, PhD; Olivier Lesieur, PhD; Maria G. Bocci, MD; Sudakshina Mullick, MD; Annette Robertsen, MD; Roshni Sreedharan, MD; Hans-Henrik Bülow, MD; Paulo A. Maia, MD; Mariá Cruz Martin-Delgado, MD; Joseph F. Cosgrove, MD; Nikki Blackwell, MD; Silvia Perez-Protto, MD; and Guy A. Richards, PhD; for the Ethicus-2 Study Group
doi : 10.1016/j.chest.2022.05.007
Volume 162, Issue 5, November 2022, Pages 1074-1085
The Relationship of Obesity and OSA to the Development of Sarcoidosis: A Large Retrospective Case-Control US Veterans Administration Analysis
Marc A. Judson, MD; Anupama Tiwari, MD; and Darren E. Gemoets, PhD
doi : 10.1016/j.chest.2022.05.008
Volume 162, Issue 5, November 2022, Pages 1086-1092
Pregnancy Considerations for Patients With Interstitial Lung Disease
Amanda Grant-Orser, MBBCh; Amy Metcalfe, PhD; Janet E. Pope, MD, MPH; and Kerri A. Johannson, MD, MPH
doi : 10.1016/j.chest.2022.06.024
Volume 162, Issue 5, November 2022, Pages 1093-1105
Pick Your Threshold: A Comparison Among Different Methods of Anaerobic Threshold Evaluation in Heart Failure Prognostic Assessment
Elisabetta Salvioni, PhD; Massimo Mapelli, MD; Alice Bonomi, PhD; Damiano Magrì, MD; Massimo Piepoli, MD; Maria Frigerio, MD; Stefania Paolillo, MD; Ugo Corrà , MD; Rosa Raimondo, MD; Rocco Lagioia, MD; Roberto Badagliacca, MD; Pasquale Perrone Filardi, MD; Michele Senni, MD; Michele Correale, MD; Mariantonietta Cicoira, MD; Enrico Perna, MD; Marco Metra, MD; Marco Guazzi, MD; Giuseppe Limongelli, MD; Gianfranco Sinagra, MD; Gianfranco Parati, MD; Gaia Cattadori, MD; Francesco Bandera, MD; Maurizio Bussotti, MD; Federica Re, MD; Carlo Vignati, MD; Carlo Lombardi, MD; Angela B. Scardovi, MD; Susanna Sciomer, MD; Andrea Passantino, MD; Michele Emdin, MD; Claudio Passino, MD; Caterina Santolamazza, MD; Davide Girola, MD; Denise Zaffalon, MD; Fabiana De Martino, MD; and Piergiuseppe Agostoni, MD, PhD; on behalf of MECKI Score Research Group
doi : 10.1016/j.chest.2022.05.039
Volume 162, Issue 5, November 2022, Pages 1106-1115
Neurovascular Dysregulation and Acute Exercise Intolerance in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Randomized, Placebo-Controlled Trial of Pyridostigmine
Phillip Joseph, MD; Rosa Pari, MD; Sarah Miller, BS; Arabella Warren, BS; Mary Catherine Stovall, BS; Johanna Squires, MSc; Chia-Jung Chang, PhD; Wenzhong Xiao, PhD; Aaron B. Waxman, MD, PhD; and David M. Systrom, MD
doi : 10.1016/j.chest.2022.04.146
Volume 162, Issue 5, November 2022, Pages 1116-1126
Executive Summary: Perioperative Management of Antithrombotic Therapy: An American College of Chest Physicians Clinical Practice Guideline
James D. Douketis, MD, FCCP; Alex C. Spyropoulos, MD, FCCP; M. Hassan Murad, MD, MPH; Juan I. Arcelus, MD; William E. Dager, PharmD; Andrew S. Dunn, MD, MPH; Ramiz A. Fargo, MD, FCCP; Jerrold H. Levy, MD; C. Marc Samama, MD; Sahrish H. Shah, MBBS; Matthew W. Sherwood, MD; Alfonso J. Tafur, MD; Liang V. Tang, MD; and Lisa K. Moores, MD, FCCP
doi : 10.1016/j.chest.2022.08.004
Volume 162, Issue 5, November 2022, Pages 1127-1139
Perioperative Management of Antithrombotic Therapy: An American College of Chest Physicians Clinical Practice Guideline
James D. Douketis, MD, FCCP; Alex C. Spyropoulos, MD, FCCP; M. Hassan Murad, MD, MPH; Juan I. Arcelus, MD; William E. Dager, PharmD; Andrew S. Dunn, MD, MPH; Ramiz A. Fargo, MD, FCCP; Jerrold H. Levy, MD; C. Marc Samama, MD; Sahrish H. Shah, MBBS; Matthew W. Sherwood, MD; Alfonso J. Tafur, MD; Liang V. Tang, MD; and Lisa K. Moores, MD, FCCP
doi : 10.1016/j.chest.2022.07.025
Volume 162, Issue 5, November 2022, Pages e207-e243
Balancing Rights and Responsibilities of Key Stakeholders in Addressing Reports of Disrespect Experienced by Patients
William O. Cooper, MD, MPH; and Gerald B. Hickson, MD
doi : 10.1016/j.chest.2022.06.001
Volume 162, Issue 5, November 2022, Pages 1140-1144
Breathing Under Water
Aleksandra Yakhkind, MD
doi : 10.1016/j.chest.2022.05.024
Volume 162, Issue 5, November 2022, Pages 1145-1146
Anticoagulation for VTE: Impact on the Risk of Major Adverse Cardiovascular Events
Steve Raoul Noumegni, MD, PhD; Raphael Le Mao, MD, PhD; Claire de Moreuil, MD, PhD; Clément Hoffmann, MD; Emmanuelle Le Moigne, MD, PhD; Cécile Tromeur, MD, PhD; Vincent Mansourati, MD; Bahaa Nasr, MD; Jean-Christophe Gentric, MD, PhD; Marie Guegan, MS; Elise Poulhazan, MS; Luc Bressollette, MD, PhD; Karine Lacut, MD, PhD; Romain Didier, MD, PhD; and Francis Couturaud, MD, PhD
doi : 10.1016/j.chest.2022.05.038
Volume 162, Issue 5, November 2022, Pages 1147-1162
Considerations When Selecting Patient-Reported Outcome Measures for Assessment of Health-Related Quality of Life in Patients With Pulmonary Hypertension: A Narrative Review
Aaron Yarlas, PhD; Stephen C. Mathai, MD, MHS; Steven D. Nathan, MD; Hilary M. DuBrock, MD; Kellie Morland, PharmD; Natalie Anderson, BA; Mark Kosinski, MA; Xiaochen Lin, PhD; and Peter Classi, MS, MBA
doi : 10.1016/j.chest.2022.08.2206
Volume 162, Issue 5, November 2022, Pages 1163-1175
Air Pollution and the Effectiveness of Positive Airway Pressure Therapy in Individuals With Sleep Apnea: A Retrospective Community-Based Repeated-Measures Longitudinal Study
Tetyana Kendzerska, MD, PhD; Mieczysław Szyszkowicz, PhD; Jonathan Villa Alvarez, BSc; Ranjeeta Mallick, PhD; Christopher Carlsten, MD, MPH; Najib Ayas, MD, MPH; Cheryl R. Laratta, MD; Branka Jovic, BSc; Juma Orach, BSc; Marc Smith-Doiron, BSc; and Robert Dales, MD
doi : 10.1016/j.chest.2022.07.017
Volume 162, Issue 5, November 2022, Pages 1176-1187
Drug-Related Pneumonitis Induced by Osimertinib as First-Line Treatment for Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer: A Real-World Setting
Yuki Sato, MD; Hiromitsu Sumikawa, MD, PhD; Ryota Shibaki, MD; Takeshi Morimoto, MD, MPH; Yoshihiko Sakata, MD; Yuko Oya, MD, PhD; Motohiro Tamiya, MD; Hidekazu Suzuki, MD; Hirotaka Matsumoto, MD; Takashi Yokoi, MD, PhD; Kazuki Hashimoto, MD; Hiroshi Kobe, MD; Aoi Hino, MD; Megumi Inaba, MD; Yoko Tsukita, MD, PhD; Hideki Ikeda, MD; Daisuke Arai, MD, PhD; Hirotaka Maruyama, MD; Satoshi Hara, MD; Shinsuke Tsumura, MD; Shinya Sakata, MD, PhD; and Daichi Fujimoto, MD, PhD
doi : 10.1016/j.chest.2022.05.035
Volume 162, Issue 5, November 2022, Pages 1188-1198
Impact of Preoperative Diagnostic Biopsy Procedure on Spread Through Airspaces and Related Outcomes in Resected Stage I Non-Small Cell Lung Cancer
Ga Young Lee, MD; Jin-Haeng Chung, MD, PhD; Sukki Cho, MD, PhD; Yeon Bi Han, MD, PhD; Young Mi Park, MS; Hyung-Jun Kim, MD; Myung Jin Song, MD; Byoung Soo Kwon, MD; Sung Yoon Lim, MD; Yeon Joo Lee, MD; Jong Sun Park, MD, PhD; Young-Jae Cho, MD, PhD; Ho Il Yoon, MD, PhD; Jae Ho Lee, MD, PhD; Choon-Taek Lee, MD, PhD; and Yeon Wook Kim, MD, PhD
doi : 10.1016/j.chest.2022.05.002
Volume 162, Issue 5, November 2022, Pages 1199-1212
Natural History of Contralateral Bullae/Blebs After Ipsilateral Video-Assisted Thoracoscopic Surgery for Primary Spontaneous Pneumothorax: A Retrospective Cohort Study
Jin Yong Jeong, MD; Ah Young Shin, MD; Jick Hwan Ha, MD; Jong Hui Suh, MD; Si Young Choi, MD; Ju Sang Kim, MD; and Chan Beom Park, MD, PhD
doi : 10.1016/j.chest.2022.05.001
Volume 162, Issue 5, November 2022, Pages 1213-1222
A Case of Thrombotic Microangiopathy and Acute Sarcoidosis
Anthony W. Martinelli, MB BChir; William Dunn, MB ChB; Mark E. McClure, MB BCh; Ieuan Walker, MB BS; Andrew Stewart, PhD; Sumit Karia, MB BS; Stephen D. Preston, FRCPath; Sathia Thiru, FRCPath; Nicholas Torpey, PhD; Sanjay Ojha, MB BChir; Emily Symington, FRCPath; and James A. Nathan, PhD
doi : 10.1016/j.chest.2022.06.023
Volume 162, Issue 5, November 2022, Pages e245-e248
A 17-Year-Old Girl Diagnosed With STING-Associated Vasculopathy With Onset in Infancy (SAVI) After Lung Transplantation
Dohyung Kim, MD; Kun Baek Song, MD; Eom Ji Choi, MD; and Jinho Yu, MD, PhD
doi : 10.1016/j.chest.2022.05.025
Volume 162, Issue 5, November 2022, Pages e249-e252
A 72-Year-Old Woman With Dyspnea, Multiple Pulmonary Nodules, and Mediastinal Lymphadenopathy
Prachi Saluja, MD; Vijay Patel, MD; Nitesh Gautam, MD; Jose Diego Caceres, MD; Nikhil K. Meena, MD; and Anand N. Venkata, MD
doi : 10.1016/j.chest.2022.05.032
Volume 162, Issue 5, November 2022, Pages e253-e257
A 52-Year-Old Man With Chest Pain and Dyspnea
Charles G. Murphy, MD; Jonathan M. Goldstein, MD; Sepideh Besharati, MD; Serge Kobsa, MD, PhD; Mary M. Salvatore, MD; Erika B. Rosenzweig, MD; Matthew Ingham, MD; Armando Del Portillo, MD, PhD; Koji Takeda, MD, PhD; Subani Chandra, MD; and David Furfaro, MD
doi : 10.1016/j.chest.2022.05.020
Volume 162, Issue 5, November 2022, Pages e259-e264
A 13-Year-Old Male Patient With Severe Multifocal Pneumonia and Bronchiectasis That Required Extracorporeal Membrane Oxygenation
Kyndall S. Smith, MD; Stanley A. Lee, MD; Brittany K. Albers, MD; Erica L. Stevens, MD; Scott G. Bickel, MD; and Adrian R. O’Hagan, MD
doi : 10.1016/j.chest.2022.06.037
Volume 162, Issue 5, November 2022, Pages e265-e271
Late Presentation of Hypotension After Cardiac Surgery
Rafal Kopanczyk, DO; Ryan Grieger, MD; and John Bozinovski, MD
doi : 10.1016/j.chest.2021.10.053
Volume 162, Issue 5, November 2022, Pages e273-e275
47-Year-Old Woman With Altered Mental Status and Lower Extremity Edema
Anthony Andrade, MD; and Kevin C. Proud, MD, FCCP
doi : 10.1016/j.chest.2021.10.052
Volume 162, Issue 5, November 2022, Pages e277-e280
Ventilatory Strategy to Prevent Atelectasis During Bronchoscopy With General Anesthesia: The Role of Laryngeal Mask Airway
Diamanto Aretha, MD, PhD Evanthia Dimitriou, MD Stella Antoniou, MD
doi : 10.1016/j.chest.2022.07.031
Volume 162, Issue 5, November 2022, Page e281
Response
Moiz Salahuddin, MD Mona Sarkiss, MD Roberto F. Casal, MD
doi : 10.1016/j.chest.2022.08.2205
Volume 162, Issue 5, November 2022, Pages e281-e282
Limitations on PassItOn Design and Execution Should Temper Negative Conclusions
Shmuel Shoham, MD Baltimore, MD Daniele Focosi, MD, PhD
doi : 10.1016/j.chest.2022.07.030
Volume 162, Issue 5, November 2022, Pages e282-e283
Late Treatment for COVID-19 With Convalescent Plasma
Jonathon W. Senefeld, PhD Rochester, MN Nigel S. Paneth, MD East Lansing, MI Rickey E. Carter, PhD Jacksonville, FL R. Scott Wright, MD Rochester, MN DeLisa Fairweather, PhD Katelyn A. Bruno, MD Jacksonville, FL Michael J. Joyner, MD
doi : 10.1016/j.chest.2022.07.029
Volume 162, Issue 5, November 2022, Pages e283-e284
COVID-19 Convalescent Plasma and Concomitant Therapies in PassITON
Arturo Casadevall, MD, PhD Baltimore, MD Jeffrey P. Henderson, MD, PhD
doi : 10.1016/j.chest.2022.07.028
Volume 162, Issue 5, November 2022, Pages e284-e285
Response
Wesley H. Self, MD, MPH Allison P. Wheeler, MD James D. Chappell, MD, PhD Isaac Thomsen, MD Jill M. Pulley, MBA Jillian P. Rhoads, PhD Gordon R. Bernard, MD Todd W. Rice, MD
doi : 10.1016/j.chest.2022.08.2204
Volume 162, Issue 5, November 2022, Pages e285-e287
COPD Risk After Military Service: Let’s Go Further Before Concluding
Nicolas Cazes, MD Anaïs Briquet, MD
doi : 10.1016/j.chest.2022.06.047
Volume 162, Issue 5, November 2022, Pages e287-e288
Response
Laura Trupin, MPH Gabriela Schmajuk, MD San Francisco, CA David Ying, MD Tampa, FL Edward Yelin, PhD Paul D. Blanc, MD
doi : 10.1016/j.chest.2022.07.006
Volume 162, Issue 5, November 2022, Page e288
Where PICU Beds Are Lacking, the Model of “Extended NICU� May Help to Treat Infants and Small Toddlers Who Are Critically Ill, Even During the COVID-19 Pandemic
Nunzia Decembrino, MD Catania, Italy Eloisa Gitto Messina, Italy Tiziana Fedeli Monza, Italy Ferdinando Spagnuolo Naples, Italy Luigi Orfeo Rome, Italy Corrado Moretti Rome, Italy Paola Cogo Udine, Italy Nicola Pozzi
doi : 10.1016/j.chest.2022.07.022
Volume 162, Issue 5, November 2022, Pages e289-e290
Response
Ryan C. Maves, MD Winston-Salem, NC Mary A. King, MD, MPH
doi : 10.1016/j.chest.2022.07.023
Volume 162, Issue 5, November 2022, Page e290
